Spark Plug Pipe

CORAL GABLES, FL / ACCESSWIRE / January 22, 2019 / The marijuana stock market around the nation has become extremely positive in the past year and beyond. With so many changes happening around the market, whether it be legislative or other, market analysts have stated that this could be the year of cannabis. With the global medical marijuana market predicted to reach $55.0 billion by 2024, according to a new research study published by Global Market Insights, Inc, it stands to reason that companies with the ability to combine the complex medical applications of cannabis with integrative healthcare frameworks could create potential opportunities from entering the nascent marijuana industry. With the new year onlyone month old, Premier Health Group (PHGRF) (PHGI) , Cronos Group Inc (NASDAQ:CRON) (TSX:CRON.TO), TerrAscend Corp (OTCQX:TRSSF), and GW Pharmaceuticals plc (NASDAQ:GWPH) are four pot stocks representing companies helping the whole of their industry move forward.

Premier Health Group (PHGRF) (PHGI) is a company focused on redesigning how medical care is received and implementing nuanced practical applications for cannabis products in the healthcare space. In recent months, the Company has made strategic investments in companies and products to introduce cannabis to the medical field, while simultaneously garnering significant support from the public as well as investors in the cannabis sector.

Premier Health Group (PHGRF) (PHGI) announced at the tail-end of last week that as part of its international expansion strategy, it has entered into a strategic partnership with China’s 360 Health, a healthcare subsidiary of 360 Security Technology. The parent company, 360 Security Technology, is a leading online service company in China with a market capitalization of over $20 billion USD as of January 16, 2019.

As part of the collaboration, Premier and 360 Health will implement an infrastructure whereby Premier will be providing second opinion services by connecting 360 Health’s patients in China with doctors in Canada both remotely and in person. Premier will also assist with General Practitioner training virtually and onsite through medical seminars.

In response to this announcement , Dr. Essam Hamza, CEO of Premier, said, “We are very excited to be working with 360 Health as China continues to adopt a Family Practice primary care model and look forward to helping them establish themselves as a leader in primary care. This partnership represents an excellent opportunity for Premier to tap into the fastest growing telemedicine market globally.”

For More Information On Premier Health Group, Click Here

Cronos Group Inc (CRON) saw its shares jump up 2.05% to $15.20 per share, following a company announcement from last week that indicated the Company had sent out meeting materials for their upcoming special meeting of shareholders to be held on February 21, 2019. According to the announcement, the documents will include information pertaining to the proposed C$2.4 billion equity investment by Altria Group Inc in Cronos Group previously announced on December 7, 2018.

For More Information On Cronos Group Inc, Click Here

TerrAscend Corp (TRSSF), a biopharmaceutical and wellness company working to manufacture and offer quality products for the global cannabinoid market, announced earlier this month that it had closed on a previously reported asset acquisition of Grander Distribution LLC. Grander is one of several industry leaders in the production and distribution of innovative hemp-derived wellness products.

For More Information on TerrAscend Corp, Click Here

GW Pharmaceuticals plc (GWPH) enjoyed impressive gains on Tuesday as its shares climbed 1.7% in mid-afternoon trading, jumping to $139.62 per share. Just before the end of 2018, the Company announced that Justin Gover, their Chief Executive Officer, would present a company update at the J.P. Morgan 2019 Healthcare Conference in San Francisco, CA at the beginning of January 2019. According to several media outlets, updates on the Company’s presentation should be made available to the public shortly.

For More Information On GW Pharmaceuticals plc, Click Here

What Is Stock Price (

Stock Price is defined as the price of a single share of a number of saleable stocks of a public company. A stock price is the highest amount an investor or trader is willing to pay for the stock, or the lowest amount that it can be bought for. was created for everyone that wants the latest stock quotes, stock charts, company news, and the best financial content.

At Stock Price (, you get free stock quotes, up-to-date news, international market data, social interaction and the best financial content that will help you manage your financial life.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. JSG Communications, LLC which owns is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.

JSG Communications, LLC, which owns , may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. JSG Communications, LLC, which owns , may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two.

Pursuant to an agreement between MIDAM VENTURES, LLC an affiliate of JSG COMMUNICATIONS LLC and Premier Health Group Inc. we were hired for a period from 10/1/2018 – 4/1/2019 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. We were paid $300,000 (CASH) for & were paid “500,000” shares of restricted common shares (as of 1/22/2019). We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6) Six-month restriction is complete on 4/1/2019 we plan to sell the “500,000” shares of Premier Health Group Inc. that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information Please click here for full disclaimer .

Contact Information: